Dogwood Therapeutics, Inc.
DWTX
$1.94
-$0.10-4.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.61M | 2.39M | 1.47M | 1.29M | 1.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.86M | 5.06M | 3.81M | 15.81M | 3.92M |
| Operating Income | -4.86M | -5.06M | -3.81M | -15.81M | -3.92M |
| Income Before Tax | -14.01M | -4.99M | -3.75M | -15.75M | -3.81M |
| Income Tax Expenses | -2.48M | 1.20K | 31.80K | -1.40K | 100.00 |
| Earnings from Continuing Operations | -11.53M | -4.99M | -3.78M | -15.74M | -3.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.53M | -4.99M | -3.78M | -15.74M | -3.81M |
| EBIT | -4.86M | -5.06M | -3.81M | -15.81M | -3.92M |
| EBITDA | -4.85M | -5.06M | -3.81M | -15.81M | -3.91M |
| EPS Basic | -0.34 | -0.15 | -0.26 | -8.20 | -1.99 |
| Normalized Basic EPS | -0.09 | -0.09 | -0.16 | -5.13 | -1.25 |
| EPS Diluted | -0.34 | -0.15 | -0.26 | -8.20 | -1.99 |
| Normalized Diluted EPS | -0.09 | -0.09 | -0.16 | -5.13 | -1.25 |
| Average Basic Shares Outstanding | 34.13M | 33.54M | 14.52M | 1.92M | 1.91M |
| Average Diluted Shares Outstanding | 34.13M | 33.54M | 14.52M | 1.92M | 1.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |